Cloned (Comment) | Organism |
---|---|
gene mak, DNA and amino acid sequence determination and analysis, phylogenetic analysis, recombinant expression of C-terminally His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3) | Mycolicibacterium vanbaalenii |
gene mak, phylogenetic analysis, recombinant expression of C-terminally His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3) | Mycobacterium tuberculosis |
Crystallization (Comment) | Organism |
---|---|
purified recombinant enzyme in complex with a non-hydrolysable ATP analogue, mixing of 0.001 ml of protein in 20 mg/ml in 50 mM BTP, pH 7.5, 50 mM NaCl, with 0.0007-0.001 ml of reservoir solution containing 0.1 M MOPS/sodium HEPES, pH 7.5, 0.12 M ethylene glycols (0.03 M each of di-, tri-, tetra-, and penta-ethyleneglycol), 30% PEG 500 MME/PEG 20000, and equilibration against 00.3 ml reservoir solution, 20°C, microseeding, X-ray diffraction structure determination and analysis at 1.15 A resolution, modelling. Crystallzation attempts of the enzyme in complex with maltose are all unsuccessful | Mycolicibacterium vanbaalenii |
Protein Variants | Comment | Organism |
---|---|---|
D334N | inactive mutant | Mycolicibacterium vanbaalenii |
D339N | inactive mutant | Mycobacterium tuberculosis |
E324R | site-directed mutagenesis, the mutant shows decreased activity compared to the wild-type enzyme | Mycolicibacterium vanbaalenii |
E340R | site-directed mutagenesis, the mutant shows decreased activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
K413A | site-directed mutagenesis | Mycolicibacterium vanbaalenii |
N137A | site-directed mutagenesis, inactive mutant | Mycolicibacterium vanbaalenii |
N145A | site-directed mutagenesis, inactive mutant | Mycobacterium tuberculosis |
R334R | site-directed mutagenesis, the mutant shows decreased activity compared to the wild-type enzyme | Mycolicibacterium vanbaalenii |
R351A | site-directed mutagenesis, the mutant shows decreased activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
S136A | site-directed mutagenesis, the mutant shows highly decreased activity compared to the wild-type enzyme | Mycolicibacterium vanbaalenii |
S144A | site-directed mutagenesis, the mutant shows highly decreased activity compared to the wild-type enzyme | Mycobacterium tuberculosis |
Y416A | site-directed mutagenesis | Mycolicibacterium vanbaalenii |
Y416F | site-directed mutagenesis | Mycolicibacterium vanbaalenii |
Y420A | site-directed mutagenesis | Mycolicibacterium vanbaalenii |
Y420F | site-directed mutagenesis | Mycolicibacterium vanbaalenii |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Mycobacterium tuberculosis | |
Mg2+ | required, magnesium-binding residue is Asp322 | Mycolicibacterium vanbaalenii |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + maltose | Mycolicibacterium vanbaalenii | - |
ADP + alpha-maltose-1-phosphate | - |
? | |
ATP + maltose | Mycobacterium tuberculosis | - |
ADP + alpha-maltose-1-phosphate | - |
? | |
ATP + maltose | Mycolicibacterium vanbaalenii DSM 7251 | - |
ADP + alpha-maltose-1-phosphate | - |
? | |
ATP + maltose | Mycobacterium tuberculosis ATCC 25618 | - |
ADP + alpha-maltose-1-phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | O07177 | - |
- |
Mycobacterium tuberculosis ATCC 25618 | O07177 | - |
- |
Mycolicibacterium vanbaalenii | A1TH50 | - |
- |
Mycolicibacterium vanbaalenii DSM 7251 | A1TH50 | - |
- |
Purification (Comment) | Organism |
---|---|
recombinant C-terminally His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity and anion exchange chromatography, followed by gel filtration | Mycolicibacterium vanbaalenii |
recombinant C-terminally His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity and anion exchange chromatography, followed by gel filtration | Mycobacterium tuberculosis |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
ATP + maltose = ADP + alpha-maltose 1-phosphate | substrate binding structures and catalytic mechanism, overview | Mycolicibacterium vanbaalenii |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + maltose | - |
Mycolicibacterium vanbaalenii | ADP + alpha-maltose-1-phosphate | - |
? | |
ATP + maltose | - |
Mycobacterium tuberculosis | ADP + alpha-maltose-1-phosphate | - |
? | |
ATP + maltose | - |
Mycolicibacterium vanbaalenii DSM 7251 | ADP + alpha-maltose-1-phosphate | - |
? | |
ATP + maltose | - |
Mycobacterium tuberculosis ATCC 25618 | ADP + alpha-maltose-1-phosphate | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | the N-terminal lobe can be divided into two subdomains: a cap N-terminal subdomain comprising the first 88 amino acid residues and an intermediate subdomain composed of an anti-parallel beta-sheet flanked by two helices. The C-terminal lobe is mostly alpha-helical. While the N-terminal cap subdomain and the C-terminal lobe are predominantly acidic, the intermediate subdomain is enriched in positively charged residues. The N-terminal cap subdomain is composed of three long antiparallel beta-strands forming a curved beta-sheet that encloses the N-terminal alpha-helix and a short two-stranded beta-sheet running perpendicular to the longest beta-sheet axis, on its concave surface. The intermediate subdomain (residues 89-200) contains a central seven-stranded beta-sheet flanked by two alpha-helical segments. A nine-residue linker (residues 201-209) containing a short beta-strand connects the intermediate subdomain and the C-terminal lobe. This last domain is composed of two central 4-helical bundles, a short beta-hairpin and a small two-stranded beta-sheet | Mycolicibacterium vanbaalenii |
Synonyms | Comment | Organism |
---|---|---|
Mak | - |
Mycolicibacterium vanbaalenii |
Mak | - |
Mycobacterium tuberculosis |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
30 | - |
assay at | Mycolicibacterium vanbaalenii |
37 | - |
assay at | Mycobacterium tuberculosis |
60 | - |
- |
Mycolicibacterium vanbaalenii |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Mycolicibacterium vanbaalenii |
7.5 | - |
assay at | Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Mycolicibacterium vanbaalenii | |
ATP | - |
Mycobacterium tuberculosis |
General Information | Comment | Organism |
---|---|---|
evolution | the enzyme belongs to the family of eukaryotic-like kinases (ELKs) with N-terminal domain topologically resembling the cystatin family of protease inhibitors. Phylogenetic analysis, overview | Mycolicibacterium vanbaalenii |
evolution | the enzyme belongs to the family of eukaryotic-like kinases (ELKs) with N-terminal domain topologically resembling the cystatin family of protease inhibitors. Phylogenetic analysis, overview | Mycobacterium tuberculosis |
metabolism | the enzyme catalyzes the fourth and last step of the GlcE pathway that channels trehalose to glycogen synthesis and is also likely involved in the biosynthesis of two other crucial polymers: intracellular methylglucose lipopolysaccharides and exposed capsular glucan | Mycolicibacterium vanbaalenii |
metabolism | the enzyme catalyzes the fourth and last step of the GlcE pathway that channels trehalose to glycogen synthesis and is also likely involved in the biosynthesis of two other crucial polymers: intracellular methylglucose lipopolysaccharides and exposed capsular glucan | Mycobacterium tuberculosis |
additional information | the enzyme shows an eukaryotic-like kinase (ELK) fold, similar to methylthioribose kinases and aminoglycoside phosphotransferases, a typical eukaryotic protein kinase-like fold. Subtle structural rearrangements occur upon nucleotide binding in the cleft between the N- and the C-terminal lobes. The enzyme has a phosphate-binding region in the N-terminal lobe that is proposed to act as an anchoring point tethering maltokinase and trehalose isomerase activities to the site of glycogen biosynthesis, ensuring correct regulation of Mak activity and possibly preventing excessive accumulation of maltose 1-phosphate. The enzyme's unusual N-terminal domain, with the 146AMLKV150 motif, containing the conserved phosphate-binding lysine residue, might regulate its phosphotransfer activity and represents the most likely anchoring point for TreS, the upstream enzyme in the pathway. Putative catalytic base is residue Asp305 | Mycolicibacterium vanbaalenii |